Gcrss VRC 612 site implementation, support and oversight / malaria clinical trial
Ended Awarded Last action
- Contract number
- 75N93021F00001
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,067,011
Award facts
- Contract value 95% obligated
-
- $1,067,010.62 Current, with exercised options
- $1,121,243.62 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- College Park, MD 20742, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $26,223 | |
| Original award | $1,040,788 |
About this award
This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) to The Emmes Company LLC, a global clinical research organization. The $1,121,243.62 task order falls under the NIAID Clinical Research Support Services 2017-2024 indefinite delivery, indefinite quantity (IDIQ) contract vehicle. The contract is for implementation, support, and oversight of a GCRSS VRC 612 site, as well as a malaria clinical trial. The Emmes Company, as a prime contractor, provides a range of services to federal agencies such as statistical expertise, data management, and operational support for clinical research. This award is not designated as a set-aside.
Quick answers
Who was awarded contract 75N93021F00001?
75N93021F00001 was awarded to The Emmes Company, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 12, 2021.
How much is contract 75N93021F00001 worth?
The government has obligated $1,067,011 on 75N93021F00001. Its potential value, with all options, is $1,121,244.
Is contract 75N93021F00001 an order under another contract?
Yes. 75N93021F00001 is a delivery order under HHSN272201700047I, an indefinite delivery contract, on NIAID Clinical Research Support Services 2017-2024.
Was contract 75N93021F00001 competed?
The extent of competition for 75N93021F00001 was full and open competition after exclusion of sources. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award